Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging pharmacodynamic assessment of clopidogrel in children with Blalock-Taussig shunts
2004-001841-14Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of clopidogrel in thrombosis, sponsored by Sanofi. Primary endpoint: Platelet aggregation inhibition. Started Feb 2005; status: completed.
02
Drugs
clopidogrel
03
Conditions
thrombosis
Beyond the preview
Go deeper on 2004-001841-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001841-14.